is tirzepatide considered a glp-1 Molecular structure of and the dual activation mechanism of Insights into the Mechanism of

Adams, T

However, SGLT2 inhibitors have stronger evidence for renal and heart failure outcomes and are generally preferred in adults with type 2 diabetes and chronic kidney disease or heart failure, unless contraindicated or not tolerated

[DOI] [PubMed] [Google Scholar] 3.Wilding JPH, Batterham RL, Calanna S, et al

"There seems to be a broad range of sensitivity to the medications among different people." In practical terms, that means a lower dose may still help with appetite, food noise and weight loss but results may be slower, less predictable or insufficient compared with the regimens that have actually been studied

Read the full article for deeper context and safety considerations: #GLP1 #ObesityCare #MedicationSafety #PatientAwareness #AJPHI To view or add a comment, sign in What is your favorite critical care topic

Richie has some Pioneer day lore he wants to clear up